XML 60 R38.htm IDEA: XBRL DOCUMENT v3.22.1
Accounting for Share-Based Payments (Tables)
12 Months Ended
Dec. 31, 2021
Share-based Payment Arrangement [Abstract]  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions The weighted-average assumptions used in the Black-Scholes option-pricing model and weighted-average grant date fair value for options granted in 2020 are as follows:
Grant Date
February 5, 2020June 30, 2020
Weighted-average assumptions used:
Expected volatility35.1 %38.7 %
Dividend yield1.79 %1.89 %
Risk-free interest rate1.66 %0.64 %
Expected term, in years1010
Weighted-average grant date fair value$4.53 $2.59 
Schedule of Activity in the Company’s Stock Option Plans
A summary of activity for the 2011 Plan is as follows:
Weighted
Average
Exercise
Price
Options
Outstanding
Weighted
Average
Contractual
Term
(in years)
Intrinsic
Value of
Options
December 31, 2019$14.26 55,468 3.8$18,331 
Granted February 5, 202013.00 123,500 
Granted June 30, 20207.33 20,000 
Exercised— — 
 Canceled, forfeited, or expired13.14 (19,437)
December 31, 2020$12.74 179,531 7.2$9,402 
Exercised12.71 (13,174)
Canceled, forfeited, or expired13.33 (22,529)
December 31, 2021$13.04 143,828 6.0$487,011 
Exercisable options$13.05 129,163 5.8$436,637 
   
Options expected to vest:Weighted
Average
Exercise
Price
Options
Outstanding
Weighted
Average
Contractual
Term
(in years)
Grant Date Fair Value
December 31, 2019$16.01 3,723 5.1$6.11 
Granted February 5, 202013.00 123,500 4.53 
Granted June 30, 20207.33 20,000 2.59 
Vested13.24 (34,786)4.68 
   Canceled, forfeited, or expired13.14 (19,437)4.62 
December 31, 2020$11.78 93,000 9.2$5.53 
Vested10.83 (55,806)3.72 
Canceled, forfeited, or expired13.33 (22,529)4.80 
December 31, 2021$13.00 14,665 8.1$4.99 
Schedule of Stock Options by Exercise Price Range
The following table summarizes information about stock options outstanding as of December 31, 2021:
Range of Exercise PricesOutstanding Stock OptionsExercisable Stock Options
SharesWeighted AverageSharesWeighted Average Exercise Price
Exercise PriceRemaining Contractual Life in Years
$11.35 9,068 $11.35 0.19,068 $11.35 
13.70 12,370 13.70 1.112,370 13.70 
14.76 8,109 14.76 2.18,109 14.76 
16.01 18,447 16.01 3.118,447 16.01 
13.00 85,834 13.00 8.171,169 13.00 
$7.33 10,000 $7.33 8.510,000 $7.33 
 143,828   129,163  
Schedule of Stock Awards Plan Activity
A summary of plan activity for the 2015 Plan is as follows:
SharesWeighted Average
Grant Date Fair Value
Outstanding December 31, 2019100,775 $13.28 
Granted February 5, 202045,418 13.00 
Granted November 10, 202050,000 5.65 
Vested(81,233)12.87 
Forfeited(17,535)13.11 
Outstanding December 31, 202097,425 $11.97 
Granted February 10, 202115,181 8.57 
Granted October 28, 20216,751 11.11 
Granted November 15, 2021751 13.32 
Vested (64,398)9.25 
Forfeited(12,129)10.54 
Outstanding December 31, 202143,581 $9.82 
A summary of the status of our inducement stock awards as of December 31, 2021, and changes during fiscal 2021, were as follows:
UnitsWeighted-Average Grant Date Fair Value
Outstanding December 31, 2020— $— 
Granted53,696 6.35 
Vested(12,516)2.35 
Forfeited/Canceled(10,324)5.96 
Outstanding December 31, 202130,856 $8.11 
Schedule of Nonvested Performance- based Units Activity
A summary of the status of our performance-based restricted stock awards as of December 31, 2021, and changes during fiscal 2021, were as follows:
UnitsWeighted-Average Grant Date Fair Value
Outstanding December 31, 201977,986 $13.66 
Granted1
36,647 13.00 
Vested2
(64,711)13.21 
Forfeited(20,558)13.73 
Outstanding December 31, 202029,364 $13.76 
Granted3
90,000 0.69 
Vested(116,260)3.66 
Forfeited(3,104)12.99 
Outstanding December 31, 2021— $— 
1 Contingent shares granted excluded from 2020
2 Excludes the vesting of an additional 5,074 shares due to performance conditions of the awards exceeding target.
3 Contingent shares granted in prior year included in 2021